Table 2.
Complications.
| Complications (n = 121) |
Retrieved Group (n = 62) |
On-Site Group (n = 59) |
p-Value |
|---|---|---|---|
| Delayed antegrade cannula | 10 (16%) | 6 (10%) | 0.33 |
| Limb ischemia | 10 (16%) | 5 (8.5%) | 0.20 |
| Tamponade | 20 (32%) | 22 (37%) | 0.57 |
| Hemothorax | 2 (3%) | 4 (6.7%) | 0.43 |
| Mediastinal washout | 24 (39%) | 26 (44%) | 0.71 |
| RP bleed | 0 | 2 (3%) | 0.23 |
| GI Bleeding | 8 (13%) | 8 (13.5%) | 0.91 |
| Neurologic event | 9 (14.5%) | 9 (15%) | 0.90 |
| LV venting | 22 (36%) | 27 (46%) | 0.25 |
| CRRT | 29 (46.8%) | 29 (49.1%) | 0.79 |
| Bacteremia | 2 (3%) | 2 (3%) | 0.96 |
| Cannula site infection | 2 (3%) | 1 (2%) | 0.59 |
| Circuit change | 15 (24%) | 4 (7%) | <0.01 |
RP—retroperitoneal, GI—gastrointestinal, LV—left ventricle, CRRT—continuous renal replacement therapy. Definitions are available in Supplementary Materials S4. Data are expressed as n (%), and p-values were generated using the chi-square test and Fisher’s exact test.